Drugs / BNT151
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04455620 | Jan 2021 → May 2024 | cancer | BioNTech SE | Terminated | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BNT151 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04455620 ↗ |
| Route | Intravenous | “intravenous (IV)” NCT04455620 ↗ |